Streptogramin-based gene regulation systems for mammalian cells

被引:197
作者
Fussenegger, M [1 ]
Morris, RP
Fux, C
Rimann, M
von Stockar, B
Thompson, CJ
Bailey, JE
机构
[1] ETH Zurich, Swiss Fed Inst Technol, Inst Biotechnol, CH-8093 Zurich, Switzerland
[2] Univ Basel, Bioctr, Dept Microbiol, CH-4056 Basel, Switzerland
关键词
gene therapy; tissue engineering; Streptomyces; Synercid; erythropoietin;
D O I
10.1038/81208
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Here we describe repressible (PipOFF) as well as inducible (PipON) systems for regulated gene expression in mammalian cells, based on the repressor Pip (pristinamycin-induced protein), which is encoded by the streptogramin resistance operon of Streptomyces coelicolor. Expression of genes placed under control of these systems was responsive to clinically approved antibiotics belonging to the streptogramin group (pristinamycin, virginiamycin, and Synercid). The versatility of these systems was demonstrated by streptogramin-regulated expression of mouse erythropoietin (EPO), human placental secreted alkaline phosphatase (SEAP), or green fluorescent protein (GFP) in diverse cell lines (BHK, CHO, HeLa, and mouse myoblasts). Analysis of isogenic constructs in CHO cells demonstrated the PipOFF system gave lower background and higher induction ratios than the widely used tetracycline-repressible (TetOFF) expression systems. The streptogramin-based expression technology was functionally compatible with the TetOFF system, thus enabling the selective use of different antibiotics to independently control two different gene activities in the same cell.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 34 条
[1]   A CHIMERIC MAMMALIAN TRANSACTIVATOR BASED ON THE LAC REPRESSOR THAT IS REGULATED BY TEMPERATURE AND ISOPROPYL BETA-D-THIOGALACTOPYRANOSIDE [J].
BAIM, SB ;
LABOW, MA ;
LEVINE, AJ ;
SHENK, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5072-5076
[2]   Gram-positive resistance: challenge for the development of new antibiotics [J].
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :1-6
[3]   Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes [J].
Baron, U ;
Schnappinger, D ;
Helbl, V ;
Gossen, M ;
Hillen, W ;
Bujard, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1013-1018
[4]  
Barriere JC, 1994, EXPERT OPIN INV DRUG, V3, P115
[5]   A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas [J].
Bebear, C ;
Bouanchaud, DH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :59-62
[6]   SECRETED PLACENTAL ALKALINE-PHOSPHATASE - A POWERFUL NEW QUANTITATIVE INDICATOR OF GENE-EXPRESSION IN EUKARYOTIC CELLS [J].
BERGER, J ;
HAUBER, J ;
HAUBER, R ;
GEIGER, R ;
CULLEN, BR .
GENE, 1988, 66 (01) :1-10
[7]   The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans [J].
Bergeron, M ;
Montay, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :129-138
[8]  
Bessis N, 1999, CLIN EXP IMMUNOL, V117, P376
[9]   MOLECULAR CHARACTERIZATION AND TRANSCRIPTIONAL ANALYSIS OF A MULTIDRUG-RESISTANCE GENE CLONED FROM THE PRISTINAMYCIN-PRODUCING ORGANISM, STREPTOMYCES-PRISTINAESPIRALIS [J].
BLANC, V ;
SALAHBEY, K ;
FOLCHER, M ;
THOMPSON, CJ .
MOLECULAR MICROBIOLOGY, 1995, 17 (05) :989-999
[10]   Modulation of erythropoietin delivery from engineered muscles in mice [J].
Bohl, D ;
Heard, JM .
HUMAN GENE THERAPY, 1997, 8 (02) :195-204